Top1031

CF Valencia Life Sciences DST

in Valencia, CA · sponsored by Cantor Fitzgerald

Historical · convertedConverted into REIT units (721 exchange) Feb 2026, as reported by Cantor Fitzgerald · last Form D Nov 16, 2022Sponsor source (opens in a new tab)

CF Valencia Life Sciences DST, sponsored by Cantor Fitzgerald, filed its first Form D with the SEC on Aug 25, 2021 for a $40.4 million offering. Converted into REIT units (721 exchange) Feb 2026, as reported by Cantor Fitzgerald.

How it ended

Moved into a REIT, per the REIT's SEC filing

Converted into REIT units (721 exchange) Feb 2026.

Date
Feb 1, 2026

Sponsor document (opens in a new tab)

Cantor Fitzgerald has 5 active offerings on record →

Key facts

Minimum investment
$250,000
From the Form D
Offering size
$40,400,000
Equity offered, per the Form D
Sold
100%
Form D, Nov 16, 2022; the % is our arithmetic
Investors reported
102
Form D, Nov 16, 2022
Selling commissions
$2,020,000 · 5.0% of offering
Form D Item 15; the % is our arithmetic
Financing
Leveraged. This offering reports mortgage debt on the property.
How it is financed ↓
Offered under
Rule 506(b)
General advertising and solicitation are not permitted under this exemption.

Figures come from SEC Form D filings unless a source is cited. Sponsor-stated figures are as reported by the sponsor; Top1031 does not independently audit them. On a 45-day clock? Find day 45 and day 180 →

Using this record to judge the sponsor? A licensed 1031 specialist from our affiliated partner can talk it through with you.

Ask a 1031 specialist about this recordFree. About: CF Valencia Life Sciences DST. Top1031 is not a broker-dealer.

What did CF Valencia Life Sciences DST own?

Reported location
Valencia, CA

How was it financed, and what did it cost to sell?

Debt

Financing
Leveraged. This offering reports mortgage debt on the property.
Converted to a REIT (721)
Yes: converted into REIT units Feb 2026
Sponsor document

Costs and terms from the Form D

Selling commissions
$2,020,000 · 5.0% of offering
Finders’ fees
$0
Paid to officers, directors and promoters
$5,260,000 · 13.0% of offering
Form D Item 16
· The filing’s note: “Estimate of certain fees, including Managing Broker-Dealer Fee, Marketing & Due Diligence Allowance, offering & organizational expenses, reimbursement of pre-paid reserves, acquisition and financing costs that may accrue to one or more related persons.”
Broker-dealers named in the Form D
17 named in the Form D
Show the firms

Individual representatives named in Item 12 are not listed.

Date of first sale
Jul 29, 2021
Minimum investment
$250,000

Form D Item 15 and Item 16 amounts may be the issuer’s estimates; each percentage is Top1031’s arithmetic on two Form D figures. Item 16 can overlap Item 15, so Top1031 does not add them together. The issuer marked these amounts as an estimate.

What does the SEC record show?

Legal Trust name
CF Valencia Life Sciences DST
SEC CIK
1880053
First Form D
Aug 25, 2021
Latest Form D
Nov 16, 2022
Filings on record
2
Offered under
Rule 506(b)
General advertising and solicitation are not permitted under this exemption.
Source filing
Read the filings on SEC EDGAR

SEC Form D filings, newest first

FiledFormOffering amountAmount soldInvestors
Form D/A$40,400,000
$40,400,000+$40,400,000
102
EDGAR
Form D$40,400,000
$0
EDGAR

Amounts, investor counts and minimums are as filed with the SEC on Form D. The change lines are Top1031’s arithmetic between consecutive filings; a new Form D notice starts a new count.

A Form D is the notice a sponsor files when it starts raising money. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.

Common questions

What happened to CF Valencia Life Sciences DST?
CF Valencia Life Sciences DST is a Historical offering. Converted into REIT units (721 exchange) Feb 2026, as reported by Cantor Fitzgerald.
Did CF Valencia Life Sciences DST convert into REIT units through a 721 exchange?
Converted into REIT units (721 exchange) Feb 2026, as reported by Cantor Fitzgerald. In a 721 exchange, or UPREIT, the DST’s property is contributed to a REIT’s operating partnership and investors receive operating-partnership units instead of cash.
How a DST-to-721 UPREIT exit works

In the news

DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current offering documents before investing.